Compugen Ltd.
A clinical-stage company developing cancer immunotherapies using an AI platform.
CGEN | TA
Overview
Corporate Details
- ISIN(s):
- IL0010852080
- LEI:
- Country:
- Israel
- Address:
- 26 Harokmim St., Bldg D, 5885849 Holon
- Website:
- https://www.cgen.com/
Description
Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-18 14:59 |
Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Tr…
|
English | 36.0 KB | ||
| 2021-12-09 14:59 |
Compugen Presents Preliminary Translational Data Demonstrating Immune Activatio…
|
English | 184.8 KB | ||
| 2021-12-09 14:59 |
Compugen Presents Preliminary Translational Data Demonstrating Immune Activatio…
|
English | 35.9 KB | ||
| 2021-11-12 15:04 |
Documents related to Collaboration Expansion with Bristol Myers Squibb alongsid…
|
English | 179.8 KB | ||
| 2021-11-12 15:04 |
Documents related to Collaboration Expansion with Bristol Myers Squibb alongsid…
|
English | 35.9 KB | ||
| 2021-11-12 14:59 |
6K-Third Quarter 2021 Results
|
English | 182.1 KB | ||
| 2021-11-12 14:59 |
6K-Third Quarter 2021 Results
|
English | 36.0 KB | ||
| 2021-11-11 14:59 |
Announces Collaboration Expansion with Bristol Myers
Squibb alongside $20 Milli…
|
English | 101.1 KB | ||
| 2021-11-11 14:59 |
Announces Collaboration Expansion with Bristol Myers
Squibb alongside $20 Milli…
|
English | 35.9 KB | ||
| 2021-11-08 14:59 |
Compugen to Present at Upcoming Investor Conferences
|
English | 85.1 KB | ||
| 2021-11-08 14:59 |
Compugen to Present at Upcoming Investor Conferences
|
English | 35.9 KB | ||
| 2021-10-26 15:59 |
o Release Third Quarter 2021 Results on
Friday, November 12, 2021
|
English | 82.6 KB | ||
| 2021-10-26 15:59 |
o Release Third Quarter 2021 Results on
Friday, November 12, 2021
|
English | 35.9 KB | ||
| 2021-10-04 15:59 |
Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed w…
|
English | 98.6 KB | ||
| 2021-10-04 15:59 |
Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed w…
|
English | 35.9 KB |
Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Compugen Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Compugen Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
